Jian Xian

Jian Xian

Auto-generated profile, based on publicly available information

Jian Xian

Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
CRClare A. Rebbeck
Clare A. Rebbeck
JXJian Xian
Jian Xian
SBSusanne Bornelöv
Susanne Bornelöv
JGJoseph Geradts
Joseph Geradts
AHAmy Hobeika
Amy Hobeika
GHGregory J. Hannon
Gregory J. Hannon
Ductal carcinoma in situ (DCIS) is considered a non-invasive precursor to breast cancer, and although associated with an increased risk of developing invasive disease, many women with DCIS will never progress beyond their in situ diagnosis. The path from normal duct to invasive ductal carcinoma (IDC) is not well understood, and efforts to do so are hampered by the substantial heterogeneity that exists between patients, and even within patients. Here we show gene expression analysis from > 2,000 individually micro-dissected ductal lesions representing 145 patients. Combining all samples into one continuous trajectory we show there is a progressive loss in basal layer integrity heading towards IDC, coupled with two epithelial to mesenchymal transitions, one early and a second coinciding with the convergence of DCIS and IDC expression profiles. We identify early processes and potential biomarkers, including CAMK2N1 , MNX1 , ADCY5 , HOXC11 and ANKRD22 , whose reduced expression is associated with the progression of DCIS to invasive breast cancer.